Finding the right dose for cancer therapeutics--can we do better?
- PMID: 20145182
- DOI: 10.1158/1078-0432.CCR-09-3246
Finding the right dose for cancer therapeutics--can we do better?
Abstract
Unlike other diseases, dose-selection for cancer therapeutics is often based on the maximum-tolerated dose in phase 1 studies involving relatively few patients. In this issue of Clinical Cancer Research, Jain and colleagues provide evidence that lower doses may be as effective as maximum-tolerated doses in the treatment of cancer patients.
Comment on
-
Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse.Clin Cancer Res. 2010 Feb 15;16(4):1289-97. doi: 10.1158/1078-0432.CCR-09-2684. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145187 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources